Evidence map›Paper›PMID 41736366›Full record

ReviewJournal of microbiology (Seoul, Korea)2026

Ribosome-associated proteins in fungal ribosome homeostasis: Conceptual opportunities for peptide-based modulation.

Yongjun Kim, Chang-Jun Ji, Seohyun Park, Junsuk Lee, Jiwoon Jung, Yejin Kim, Dabin Pyeon, Yoon-Mo Yang

Abstract readReview
In one paragraph

Review in Journal of microbiology (Seoul, Korea), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pioneering strategies for overcoming bacterial drug resistance.Journal of microbiology (Seoul, Korea) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yongjun KimGraduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Chang-Jun JiDepartment of Life Science and Research Institute for Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea.
Seohyun ParkGraduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Junsuk LeeGraduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Jiwoon JungGraduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Yejin KimGraduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Dabin PyeonGraduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Yoon-Mo YangGraduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.

Funding

Ministry of Science and ICT RS-2024-00349721National Research Foundation of Korea
6 · The paper itself

Abstract

Ribosomes are essential macromolecular machines that facilitate protein synthesis and have long been recognized as effective targets for antimicrobial agents. While structural differences between prokaryotic and eukaryotic ribosomes form the basis for selective antibiotics against bacteria, similar approaches for developing antifungal agents targeting ribosomes have remained limited due to the high sequence and structural conservation with human ribosomes. However, emerging insights into ribosome homeostasis, including ribosome biogenesis, turnover, and hibernation, have uncovered a set of ribosome-associated proteins whose function is critical yet display greater sequence divergence from their human counterparts. These observations suggest that these regulatory components may represent viable antifungal targets by disrupting fungal proteostasis. The present review aims to explore this developing concept by examining ribosome-associated factors and considering whether short ribosomal protein-derived peptides may eventually serve as druggable molecules for selectively modulating these pathways in fungal pathogens.

Indexed as

Fungal ProteinsFungiPeptidesRibosomal ProteinsRibosomesAntifungal AgentsHomeostasisHumansProtein BiosynthesisAntifungal AgentsFungal ProteinsPeptidesRibosomal Proteinsantifungal peptideribosomal proteinribosome homeostasis

Identifiers

PMID41736366
PMCPMC13577076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.